MEDTRONIC PLC (MDT) Fundamental Analysis & Valuation

NYSE:MDTIE00BTN1Y115

Current stock price

83.79 USD
+0.57 (+0.68%)
At close:
83.79 USD
0 (0%)
After Hours:

This MDT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. MDT Profitability Analysis

1.1 Basic Checks

  • MDT had positive earnings in the past year.
  • In the past year MDT had a positive cash flow from operations.
  • MDT had positive earnings in each of the past 5 years.
  • In the past 5 years MDT always reported a positive cash flow from operatings.
MDT Yearly Net Income VS EBIT VS OCF VS FCFMDT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • With an excellent Return On Assets value of 5.04%, MDT belongs to the best of the industry, outperforming 80.21% of the companies in the same industry.
  • MDT has a better Return On Equity (9.42%) than 81.28% of its industry peers.
  • MDT has a better Return On Invested Capital (6.57%) than 80.75% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for MDT is below the industry average of 9.12%.
  • The last Return On Invested Capital (6.57%) for MDT is above the 3 year average (6.35%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.04%
ROE 9.42%
ROIC 6.57%
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
MDT Yearly ROA, ROE, ROICMDT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

1.3 Margins

  • MDT has a better Profit Margin (13.00%) than 88.24% of its industry peers.
  • MDT's Profit Margin has declined in the last couple of years.
  • MDT's Operating Margin of 18.98% is amongst the best of the industry. MDT outperforms 91.44% of its industry peers.
  • MDT's Operating Margin has been stable in the last couple of years.
  • With a decent Gross Margin value of 65.16%, MDT is doing good in the industry, outperforming 70.59% of the companies in the same industry.
  • MDT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.98%
PM (TTM) 13%
GM 65.16%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
MDT Yearly Profit, Operating, Gross MarginsMDT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

5

2. MDT Health Analysis

2.1 Basic Checks

  • MDT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, MDT has less shares outstanding
  • Compared to 5 years ago, MDT has less shares outstanding
  • MDT has a worse debt/assets ratio than last year.
MDT Yearly Shares OutstandingMDT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
MDT Yearly Total Debt VS Total AssetsMDT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

  • An Altman-Z score of 2.83 indicates that MDT is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • MDT has a better Altman-Z score (2.83) than 67.38% of its industry peers.
  • MDT has a debt to FCF ratio of 5.19. This is a neutral value as MDT would need 5.19 years to pay back of all of its debts.
  • MDT has a Debt to FCF ratio of 5.19. This is in the better half of the industry: MDT outperforms 75.40% of its industry peers.
  • MDT has a Debt/Equity ratio of 0.57. This is a neutral value indicating MDT is somewhat dependend on debt financing.
  • MDT's Debt to Equity ratio of 0.57 is on the low side compared to the rest of the industry. MDT is outperformed by 62.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 5.19
Altman-Z 2.83
ROIC/WACC1
WACC6.6%
MDT Yearly LT Debt VS Equity VS FCFMDT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • A Current Ratio of 2.54 indicates that MDT has no problem at all paying its short term obligations.
  • MDT's Current ratio of 2.54 is in line compared to the rest of the industry. MDT outperforms 47.06% of its industry peers.
  • A Quick Ratio of 1.87 indicates that MDT should not have too much problems paying its short term obligations.
  • The Quick ratio of MDT (1.87) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.54
Quick Ratio 1.87
MDT Yearly Current Assets VS Current LiabilitesMDT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

4

3. MDT Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.87% over the past year.
  • Measured over the past 5 years, MDT shows a small growth in Earnings Per Share. The EPS has been growing by 3.68% on average per year.
  • MDT shows a small growth in Revenue. In the last year, the Revenue has grown by 6.88%.
  • The Revenue has been growing slightly by 3.01% on average over the past years.
EPS 1Y (TTM)4.87%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%-2.16%
Revenue 1Y (TTM)6.88%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%8.74%

3.2 Future

  • Based on estimates for the next years, MDT will show a small growth in Earnings Per Share. The EPS will grow by 7.10% on average per year.
  • Based on estimates for the next years, MDT will show a small growth in Revenue. The Revenue will grow by 6.02% on average per year.
EPS Next Y2.83%
EPS Next 2Y5.59%
EPS Next 3Y6.24%
EPS Next 5Y7.1%
Revenue Next Year7.95%
Revenue Next 2Y7.24%
Revenue Next 3Y6.44%
Revenue Next 5Y6.02%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MDT Yearly Revenue VS EstimatesMDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B
MDT Yearly EPS VS EstimatesMDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

6

4. MDT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.96, which indicates a correct valuation of MDT.
  • 87.70% of the companies in the same industry are more expensive than MDT, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.47, MDT is valued a bit cheaper.
  • With a Price/Forward Earnings ratio of 13.66, MDT is valued correctly.
  • MDT's Price/Forward Earnings ratio is rather cheap when compared to the industry. MDT is cheaper than 88.77% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.62, MDT is valued a bit cheaper.
Industry RankSector Rank
PE 14.96
Fwd PE 13.66
MDT Price Earnings VS Forward Price EarningsMDT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 87.17% of the companies in the same industry are more expensive than MDT, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, MDT is valued cheaply inside the industry as 89.84% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 19.89
EV/EBITDA 12.23
MDT Per share dataMDT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MDT does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of MDT may justify a higher PE ratio.
PEG (NY)5.28
PEG (5Y)4.06
EPS Next 2Y5.59%
EPS Next 3Y6.24%

7

5. MDT Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.32%, MDT has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.25, MDT pays a better dividend. On top of this MDT pays more dividend than 97.86% of the companies listed in the same industry.
  • MDT's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.32%

5.2 History

  • The dividend of MDT has a limited annual growth rate of 5.10%.
  • MDT has paid a dividend for at least 10 years, which is a reliable track record.
  • MDT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)5.1%
Div Incr Years12
Div Non Decr Years12
MDT Yearly Dividends per shareMDT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • MDT pays out 78.65% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of MDT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP78.65%
EPS Next 2Y5.59%
EPS Next 3Y6.24%
MDT Yearly Income VS Free CF VS DividendMDT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
MDT Dividend Payout.MDT Dividend Payout, showing the Payout Ratio.MDT Dividend Payout.PayoutRetained Earnings

MDT Fundamentals: All Metrics, Ratios and Statistics

MEDTRONIC PLC

NYSE:MDT (4/23/2026, 8:25:33 PM)

After market: 83.79 0 (0%)

83.79

+0.57 (+0.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-17
Earnings (Next)06-03
Inst Owners87.92%
Inst Owner Change-0.23%
Ins Owners0.28%
Ins Owner Change-1.38%
Market Cap107.58B
Revenue(TTM)35.48B
Net Income(TTM)4.61B
Analysts76.22
Price Target111.21 (32.72%)
Short Float %1.33%
Short Ratio1.97
Dividend
Industry RankSector Rank
Dividend Yield 3.32%
Yearly Dividend2.77
Dividend Growth(5Y)5.1%
DP78.65%
Div Incr Years12
Div Non Decr Years12
Ex-Date03-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.66%
Min EPS beat(2)0.89%
Max EPS beat(2)2.43%
EPS beat(4)4
Avg EPS beat(4)1.6%
Min EPS beat(4)0.89%
Max EPS beat(4)2.43%
EPS beat(8)6
Avg EPS beat(8)1.11%
EPS beat(12)9
Avg EPS beat(12)1.9%
EPS beat(16)11
Avg EPS beat(16)1.33%
Revenue beat(2)2
Avg Revenue beat(2)0.17%
Min Revenue beat(2)0.08%
Max Revenue beat(2)0.26%
Revenue beat(4)4
Avg Revenue beat(4)0.35%
Min Revenue beat(4)0.08%
Max Revenue beat(4)0.91%
Revenue beat(8)7
Avg Revenue beat(8)0.23%
Revenue beat(12)10
Avg Revenue beat(12)0.48%
Revenue beat(16)12
Avg Revenue beat(16)0.07%
PT rev (1m)-1.8%
PT rev (3m)-0.45%
EPS NQ rev (1m)-3.45%
EPS NQ rev (3m)-5.15%
EPS NY rev (1m)-0.7%
EPS NY rev (3m)-0.78%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)0.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.26%
Valuation
Industry RankSector Rank
PE 14.96
Fwd PE 13.66
P/S 3.03
P/FCF 19.89
P/OCF 14.77
P/B 2.2
P/tB N/A
EV/EBITDA 12.23
EPS(TTM)5.6
EY6.68%
EPS(NY)6.13
Fwd EY7.32%
FCF(TTM)4.21
FCFY5.03%
OCF(TTM)5.67
OCFY6.77%
SpS27.64
BVpS38.15
TBVpS-2.53
PEG (NY)5.28
PEG (5Y)4.06
Graham Number69.3353 (-17.25%)
Profitability
Industry RankSector Rank
ROA 5.04%
ROE 9.42%
ROCE 8.21%
ROIC 6.57%
ROICexc 7.32%
ROICexgc 25.19%
OM 18.98%
PM (TTM) 13%
GM 65.16%
FCFM 15.24%
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
ROICexc(3y)7.09%
ROICexc(5y)7.05%
ROICexgc(3y)29.85%
ROICexgc(5y)33.32%
ROCE(3y)7.94%
ROCE(5y)7.8%
ROICexgc growth 3Y-11.61%
ROICexgc growth 5Y-5.52%
ROICexc growth 3Y-2.49%
ROICexc growth 5Y3.26%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
F-Score7
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 5.19
Debt/EBITDA 2.84
Cap/Depr 60.84%
Cap/Sales 5.28%
Interest Coverage 8.77
Cash Conversion 74.21%
Profit Quality 117.26%
Current Ratio 2.54
Quick Ratio 1.87
Altman-Z 2.83
F-Score7
WACC6.6%
ROIC/WACC1
Cap/Depr(3y)59.68%
Cap/Depr(5y)55.94%
Cap/Sales(3y)5.04%
Cap/Sales(5y)4.79%
Profit Quality(3y)124.85%
Profit Quality(5y)125.74%
High Growth Momentum
Growth
EPS 1Y (TTM)4.87%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%-2.16%
EPS Next Y2.83%
EPS Next 2Y5.59%
EPS Next 3Y6.24%
EPS Next 5Y7.1%
Revenue 1Y (TTM)6.88%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%8.74%
Revenue Next Year7.95%
Revenue Next 2Y7.24%
Revenue Next 3Y6.44%
Revenue Next 5Y6.02%
EBIT growth 1Y4.15%
EBIT growth 3Y-1.62%
EBIT growth 5Y3.4%
EBIT Next Year18.42%
EBIT Next 3Y11.24%
EBIT Next 5Y9.86%
FCF growth 1Y9.67%
FCF growth 3Y-4.64%
FCF growth 5Y-2.95%
OCF growth 1Y12.56%
OCF growth 3Y-1.39%
OCF growth 5Y-0.53%

MEDTRONIC PLC / MDT Fundamental Analysis FAQ

What is the fundamental rating for MDT stock?

ChartMill assigns a fundamental rating of 6 / 10 to MDT.


What is the valuation status for MDT stock?

ChartMill assigns a valuation rating of 6 / 10 to MEDTRONIC PLC (MDT). This can be considered as Fairly Valued.


Can you provide the profitability details for MEDTRONIC PLC?

MEDTRONIC PLC (MDT) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for MDT stock?

The Price/Earnings (PE) ratio for MEDTRONIC PLC (MDT) is 14.96 and the Price/Book (PB) ratio is 2.2.


Can you provide the dividend sustainability for MDT stock?

The dividend rating of MEDTRONIC PLC (MDT) is 7 / 10 and the dividend payout ratio is 78.65%.